Immunoprotein Diagnostic Testing Market Regional Analysis:
APAC Market Insights
The immunoprotein diagnostic testing market in the Asia Pacific is estimated to hold the highest share of 35% during the forecast period. This can be assumed due to the extremely rapid economic development coupled with the rapid development of medical health systems in countries such as China and India. Collaboration between public health organizations in China, such as the Ministry of Health, China CDC, and the US CDC, focuses on China's healthcare structure related to HIV/AIDS, vaccination, emerging infectious diseases, non-communicable diseases, and laboratory quality control, have also driven the growth of the market in this area.
North America Market Insights
The North America immunoprotein diagnostic testing market is expected to grow substantially during the forecast timeframe. Key factors driving market growth in North America include increased healthcare spending and increased awareness of products related to autoimmune disease diagnostics. North America is expected to emerge as a dominant region due to the growing disease burden as well as the development and launch of new products. Furthermore, new product approvals and launches in the region along with collaborations among key market players will drive market growth. For example, in May 2022, OmegaQuant launched an HbA1c test with a sample collection kit for at-home testing. This simple, safe, and practical test measures the amount of sugar (glucose) in the blood. Therefore, it will positively influence the market and witness significant growth in North America during the forecast period due to the above-mentioned factors.
